This approach has been really pioneered by Sputnik V in the beginning. So we are open for mix and match a Covishield in India. We believe there will be a great result. Covishield is the same vaccine as AstraZeneca so we believe that trials will show high efficacy. We hope that the Serum Institute of India (SII) can produce Sputnik V and mix and match as well. It will be a true partnership,” said Dmitriev.
Category:
Health
Latest
Top WHO scientist flags ‘dangerous trend’ of mixing Covid-19 vaccines
Addressing a Covid-19 media briefing, Swaminathan said, “Really want to caution folks, because there is a tendency now for people in countries which enough availability of vaccines to voluntarily start thinking.”
“So it’s a little bit of a dangerous trend here where we’re in a data-free evidence-free zone as far as a mix and match there is limited data on mix and match. There are studies going on, we need to wait for that,” she added.
On the question of booster shots, WHO chief scientist said it will be a chaotic situation in countries if citizens start deciding when they should be taking a second, or a third, or a fourth dose.
Abbott launches Covid-19 home test kit in India
The company will deliver millions of Panbio Covid-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India, Abbott said in a statement.
In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases, it added.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.